UC AKT.ANL. 12/24 RWE/ DE000HC7QNF1 /
| 26/07/2024 21:46:24 | Chg.+0.450 | Bid21:59:32 | Ask21:59:32 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 97.660EUR | +0.46% | 97.610 Bid Size: 70,000 |
97.760 Ask Size: 70,000 |
RWE AG INH O.N. | 32.00 - | 31/12/2024 | Call |
GlobeNewswire
25/06
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
18/06
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
12/06
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
11/06
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
05/06
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
04/06
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
23/05
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
20/05
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
13/05
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
02/05
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
25/04
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
